Tenax Therapeutics, Inc.

NASDAQ:TENX

Biotechnology

Healthcare
$1.91 +0.88%

+$0.10 today

Market cap
$50.66M
Beta
0.97
P/E (TTM)
-9.4
EPS (TTM)
-$1.28
52W Low $5.34High $18.38

Volume 0.70M

Average 0.62M

Income Statement

Follow revenue through to earnings.

Revenue

$0.00

FY 2025 · Annual

Operating Income

-$56.38M

FY 2025 · Annual

Net Income

-$52.60M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue00000
Gross Profit00000
Gross Margin—————
Research & Development25.15M5.38M3.23M12.71M32.67M
Selling, General & Admin7.58M5.68M5.01M6.79M23.71M
Operating Expenses32.73M11.05M8.23M19.49M56.39M
Depreciation & Amortization108.98K113.33K8K00
EBITDA(32.36M)(10.93M)(7.68M)(17.58M)(52.6M)
EBITDA Margin—————
Operating Income(32.73M)(11.05M)(8.23M)(19.49M)(56.39M)
Operating Margin—————
Interest Income0001.91M3.82M
Interest Expense9494.44K23.97K23K0
Other Income / Expenses253.88K4.75K523K1.89M3.79M
Income Before Tax(32.47M)(11.05M)(7.71M)(17.6M)(52.6M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(32.47M)(11.05M)(7.71M)(17.6M)(52.6M)
Net Margin—————
EPS (Basic)(2,524.80)(600.80)(31.09)(1.15)(1.34)
EPS (Diluted)(2,524.80)(600.80)(31.04)(1.15)(1.34)
Weighted Avg Shares12.86K18.39K248K15.27M39.22M
Weighted Avg Shares (Diluted)12.86K18.39K248.45K15.27M39.22M

TENX Earnings Waterfall · TTM

NASDAQ:TENX · Revenue to Net Income

Key Ratios

EPS$-1.41
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-7.3
P/S Ratio0.0

Analysis

$0 of revenue converted into -$57.9M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-1.41, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipSep 17, 2026
4Statement of changes in beneficial ownershipSep 15, 2026
4Statement of changes in beneficial ownershipSep 15, 2026
SC 13G/ASC 13G/A filingSep 11, 2026
8-KCurrent reportSep 9, 2026

How much revenue does TENX generate?

Tenax Therapeutics, Inc. (TENX) reported $0.00 of revenue in fiscal 2025.

Is TENX profitable?

Tenax Therapeutics, Inc. (TENX) reported -$52.60M of net income.